These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 28782465)
61. Multidrug resistance reversal in human gastric carcinoma cells by neferine. Cao JG; Tang XQ; Shi SH World J Gastroenterol; 2004 Oct; 10(20):3062-4. PubMed ID: 15378795 [TBL] [Abstract][Full Text] [Related]
62. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition. Kim JY; Park YJ; Lee BM; Yoon S Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902 [TBL] [Abstract][Full Text] [Related]
63. Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents. Zhu J; Wang R; Lou L; Li W; Tang G; Bu X; Yin S J Med Chem; 2016 Jul; 59(13):6353-69. PubMed ID: 27328029 [TBL] [Abstract][Full Text] [Related]
64. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137 [TBL] [Abstract][Full Text] [Related]
65. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
66. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528 [TBL] [Abstract][Full Text] [Related]
67. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells. Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273 [TBL] [Abstract][Full Text] [Related]
68. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
69. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
70. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts. Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047 [TBL] [Abstract][Full Text] [Related]
71. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Li S; Zhao Q; Wang B; Yuan S; Wang X; Li K Phytother Res; 2018 Aug; 32(8):1530-1536. PubMed ID: 29635751 [TBL] [Abstract][Full Text] [Related]
72. Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519. Che XF; Nakajima Y; Sumizawa T; Ikeda R; Ren XQ; Zheng CL; Mukai M; Furukawa T; Haraguchi M; Gao H; Sugimoto Y; Akiyama S Cancer Lett; 2002 Dec; 187(1-2):111-9. PubMed ID: 12359358 [TBL] [Abstract][Full Text] [Related]
73. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction. Zhao Y; Xiao B; Chen B; Qiao T; Fan D Chin Med J (Engl); 2000 Nov; 113(11):977-80. PubMed ID: 11776130 [TBL] [Abstract][Full Text] [Related]
74. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765 [TBL] [Abstract][Full Text] [Related]
75. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance. Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724 [TBL] [Abstract][Full Text] [Related]
76. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476 [TBL] [Abstract][Full Text] [Related]
77. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231 [TBL] [Abstract][Full Text] [Related]
78. [Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine]. Huang YH; Zhang SH; Zhen RX; Xu XD; Zhen YS Ai Zheng; 2004 Dec; 23(12):1599-604. PubMed ID: 15601545 [TBL] [Abstract][Full Text] [Related]
79. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J; Wang FP; Wei H; Liu G Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274 [TBL] [Abstract][Full Text] [Related]
80. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]